Hadassah

Hadassah Mourns the Loss of Aretha Franklin and Urges Greater Awareness of Diagnosis and Treatment of Pancreatic Cancer

Friday, Aug 17 2018

Aretha Franklin (Courtesy CSU Archives/Everett Collection)

Sadly, the “queen of soul” Aretha Franklin passed away yesterday at age 76, due to an advanced pancreatic neuroendocrine tumor (pancreatic NET or PNET). 

Beloved by countless fans for the transcendent, timeless, and deeply moving quality of her music, Aretha left a legacy that musicians and music lovers will cherish.  Hadassah offers its condolences to Ms. Franklin’s family and relatives on the passing of this American music icon and legend.  The PNET that took Aretha’s life is a rare cancer (~ six percent of all pancreatic tumors), which develops from the abnormal growth of endocrine (hormone-producing) cells in the pancreas.

As Dr. Simona Glasberg, head of the Neuroendocrine Tumor Unit at the Hadassah Medical Organization, explains, "One of the major issues with these tumors is their timely diagnosis, as many times they are missed. Increasing awareness within the medical community and general population of these rare tumors is extremely important, as is the timely referral to a specialized center that is experienced in treating these rare cancers."

Whereas PNETs tend to grow slower than the usual aggressive pancreatic adenocarcinoma, Dr. Glasberg says, “they always have a malignant potential to spread locally or to other organs.  Often, they are diagnosed at an advanced stage of metastatic disease. The symptoms of PNETs are usually related to the tumor-mass growth and spread (e.g., abdominal pain, weight loss, loss of appetite, jaundice, etc.). However, in about 25 percent of cases, these tumors may produce specific hormonal-hypersecretion syndromes, causing diarrhea, severe weakness, sweating, and loss of consciousness. The Neuroendocrine Tumor Unit at Hadassah, with its dedicated multidisciplinary team, is a global leader in NET treatment and research.  Recently,  the European Neuroendocrine Tumor Society (ENETS) certified Hadassah’s unit as the only center of excellence in Israel and the Middle East.  

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, May 16 2019

First of Its Kind in Israel: Cardiac Catheterization at Hadassah on Under Two-Pound Baby

A cardiac catheterization, the first of its kind in Israel, was successfully performed this week at Hadassah Hospital Ein Kerem on a fragile premature infant, weighing under two pounds.

READ MORE ›
alt_text

Wednesday, May 15 2019

How Much Do You Know About Your Liver and Hadassah’s Life-Saving Liver Treatments?

Three pounds of reddish-brown tissue tucked under the diaphragm, your liver churns out over 1,000 different types of enzymes to help you digest food, store energy, and wash out toxins

READ MORE ›
alt_text

Wednesday, May 15 2019

Affirming Our Commitment to Reproductive Rights

I’m proud of Hadassah’s longstanding commitment to advancing women’s health, through the exemplary research and care at Hadassah Medical Organization, as well as our health education and grassroots advocacy here in the United States.

READ MORE ›
alt_text

Monday, May 13 2019

Grappling with Life Post-Trauma: Hadassah Therapist Offers Advice

As we return to normal life in the aftermath of terror attacks, whether in synagogues, churches, or other settings in our local communities, how do we cope?

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More